BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
CLSA Initiates Buy on Glenmark Pharmaceuticals
CLSA has initiated buy rating on Glenmark Pharmaceuticals with a target price of Rs 1,060. CLSA in a note to its clients said that the earnings growth is likely to revive on pick in approvals from US.